Related Experiment Video
Updated: Apr 14, 2026
09:43
Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
6.9K
Big Data Technologies: New Opportunities for Diabetes Management.
Riccardo Bellazzi1, Arianna Dagliati2, Lucia Sacchi2
1Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy IRCCS Fondazione S. Maugeri, Pavia, Italy riccardo.bellazzi@unipv.it.
Journal of Diabetes Science and Technology
|April 26, 2015
Summary
Big data offers new ways to manage diabetes by integrating diverse information sources and utilizing advanced technologies. This approach enhances patient care insights and supports decision-making in chronic disease management.
Area of Science:
- Health Informatics
- Diabetes Management
- Data Science
Background:
- The big data revolution presents significant opportunities for improving diabetes care.
- Current approaches to diabetes management can be enhanced by leveraging large, diverse datasets.
Purpose of the Study:
- To review the concepts and applications of big data in healthcare.
- To discuss the potential impact of big data on diabetes management strategies.
- To present the MOSAIC project as a case study of big data implementation in diabetes care.
Main Methods:
- Review of big data concepts and definitions.
- Exploration of current healthcare applications of big data.
- Case study analysis of the MOSAIC project.
Main Results:
- Big data integration offers novel insights into patient care processes and behaviors.
- Advanced diabetes technologies necessitate distributed platforms for real-time data analysis and decision support.
- Incorporating geographical and environmental data can enhance data interpretation and knowledge extraction.
Conclusions:
- Big data holds significant potential to revolutionize diabetes management.
- Integrating diverse data sources, leveraging new technologies, and including environmental factors are key to unlocking this potential.
- The MOSAIC project exemplifies the practical application of big data in diabetes care research.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Type 2 and Gestational
5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
01:29Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
988
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
988